©The Author(s) 2025.
World J Gastrointest Oncol. Oct 15, 2025; 17(10): 110203
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.110203
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.110203
Table 2 Tumor-nodes-metastasis classification, n (%)
| Variables | n = 52 |
| Classification T | |
| T1 | 29 (55.7) |
| T2 | 8 (15.4) |
| T3 | 11 (21.2) |
| T4 | 4 (7.7) |
| Classification N | |
| N0 | 31 (59.6) |
| N1 | 21 (40.4) |
| Classification M | |
| M0 | 33 (63.5) |
| M1 | 19 (36.5) |
| Stage | |
| I | 25 (48.1) |
| II | 3 (5.8) |
| III | 5 (9.6) |
| IV | 19 (36.5) |
| Disease stage | |
| Localized | 29 (55.8) |
| Advanced | 23 (44.2) |
| Status of advanced disease, n = 23 | |
| Metastatic | 19 (82.6) |
| Recurrent | 3 (13.0) |
| Unresectable | 1 (4.3) |
- Citation: Cruz-Diaz WE, Leonardo A, Saavedra A, Paitan V, Haro-Varas J, Mantilla R, Macetas J, Veramendi E, Pacheco C, Calderón M, Vidaurre T, Castro-Oliden V. Rectal neuroendocrine tumors in a Latin American population: Insights from a Peruvian national cancer institute. World J Gastrointest Oncol 2025; 17(10): 110203
- URL: https://www.wjgnet.com/1948-5204/full/v17/i10/110203.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i10.110203